![[The Medical Innovation Paradox: How Breakthrough Approvals Mask a Deeper Crisis in Drug Development]](https://www.crimaz.com/assets/images/no-image.png)
[The Medical Innovation Paradox: How Breakthrough Approvals Mask a Deeper Crisis in Drug Development]
[The FDA's September 2026 approval of Zanvastro for Alexander disease and oral GLP-1 obesity pills, alongside null findings on maternal diet for aller...
Read Full Story →




